Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
6.56
+0.56 (9.33%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $3.86 million as of April 24, 2025. Its market cap has increased by 28.61% in one year.
Market Cap
3.86M
Enterprise Value
-7.27M
1-Year Change
28.61%
Ranking
Category
Stock Price
$6.56
Market Cap Chart
Since August 1, 2016, Quoin Pharmaceuticals's market cap has decreased from $28.60M to $3.86M, a decrease of -86.51%. That is a compound annual growth rate of -20.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 6.20M | 87.88% |
| Dec 31, 2024 | 3.30M | -31.25% |
| Dec 29, 2023 | 4.80M | -30.43% |
| Dec 30, 2022 | 6.90M | -54.61% |
| Dec 31, 2021 | 15.20M | 80.95% |
| Dec 31, 2020 | 8.40M | 68.00% |
| Dec 31, 2019 | 5.00M | -60.32% |
| Dec 31, 2018 | 12.60M | -66.58% |
| Dec 29, 2017 | 37.70M | 125.75% |
| Dec 30, 2016 | 16.70M | -41.61% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.41B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |